510(k) Report

510(k) · Cleared

Cleared

CardiMax Electrocardiograph

K173226510(k) TraditionalCleared Apr 16, 2018195-day reviewClass II21 CFR 870.2340

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Fukuda Denshi USA, Inc. · DPS Electrocardiograph

Cleared on Apr 16, 2018 as substantially equivalent to K981066 (Fukuda Denshi USA, Inc., 1998) and 1 other predicate after a 195-day review. Its family tree reaches back 3 generations to 1991.

Decided
Apr 16, 2018
Review
195 days
Class
Class II
Product code
DPS
Recalls
None
Predicates
2

Its longest line of descent runs back 3 generations to K913811 (1991). 6 ancestors in all. No later device cites it as a predicate yet.

  1. Root · 3 generations backK913811 Fukuda Denshi Model FCP-4101Fukuda Denshi USA, Inc. · 1991
  2. 2 generations backK971440 Fukuda Denshi Model FCP-2155 Multi Channel, Interpretive…Fukuda Denshi USA, Inc. · 1997
  3. 1 generation backK981066 Fukuda Denshi: Cardiomax, Model FX-4010 Multi Channel…Fukuda Denshi USA, Inc. · 1998
  4. This deviceK173226 CardiMax ElectrocardiographFukuda Denshi USA, Inc. · 2018
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−3K913811Fukuda Denshi Model FCP-4101Fukuda Denshi USA, Inc.1991—
−2K971440Fukuda Denshi Model FCP-2155 Multi Channel, Interpretive ElectrocardiographFukuda Denshi USA, Inc.1997—
−1K981066Fukuda Denshi: Cardiomax, Model FX-4010 Multi Channel ElectrocardiographFukuda Denshi USA, Inc.1998—
0 (this device)K173226CardiMax ElectrocardiographFukuda Denshi USA, Inc.2018—

Other ancestors by year cleared

Year clearedDevicesWith a Class I recall
199910
200610
200710
FIG. 1 — Lineage of K173226, 1991–2018Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in DPS? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new DPS device

  1. #1 K212112 Cardiologs Holter Platformscore 18.6 · 5 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (2)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K981066Fukuda Denshi: Cardiomax, Model FX-4010 Multi Channel Electrocardiograph
Summary page 4
…II • Review Panel: Cardiovascular Predicate Devices: Fukuda Denshi Cardiograph Model FX-4010 Electrocardiograph, 510(k) # K981066. The 12-Lead ECG analysis software module which modified any functions used in the FX-8322 is…
Fukuda Denshi USA, Inc.1998—
*K072217Ecg-1250A Series Cardiofax S and Ecg-1350A Series Cardiofax M
Summary page 4
…10 Multi Channel Electrocardiograph cleared under 510(k) # K981066 and the Nihon Kohden Cardiofax model ECG-1350A cleared under 510(k) #K072217. FX-8322 510(k) 510(k) Summary…
Nihon Kohden America, Inc.2007—

Also cleared against K981066: 1 other device →

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 27 years and passes through 1 company; a new generation was cleared every 6.0 years on median.
  • None of the 6 ancestors has a recall.
  • 1 other device also cites its predicate K981066.

How does its category compare?

All DPS devices

DPS Electrocardiograph: FDA decisions, review times, recalls and adverse event reports over 20 years. 2018, this device’s year, is highlighted.

FDA decisions per year · DPS

6in 2025

2007: 112008: 132009: 142010: 112011: 222012: 122013: 102014: 112015: 82016: 112017: 92018: 142019: 32020: 62021: 52022: 62023: 102024: 82025: 62026 (partial year): 6
2007high 22 (2011) · low 3 (2019)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · DPS

163in 2025

2007: 87 days median2008: 31 days median2009: 84 days median2010: 104 days median2011: 154 days median2012: 117 days median2013: 134 days median2014: 253 days median2015: 178 days median2016: 229 days median2017: 177 days median2018: 221 days median2019: 178 days median2020: 224 days median2021: 135 days median2022: 244 days median2023: 236 days median2024: 260 days median2025: 163 days median2026 (partial year): 258 days median
2007high 260 (2024) · low 31 (2008)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · DPS

3in 2025

2007: 22009: 12010: 22011: 12019: 92020: 22021: 12022: 12023: 32024: 4, 1 Class I2025: 32026 (partial year): 4
2007high 9 (2019) · low 0 (2008)2026

Class I (1 since 2007) Class II/III not classified

Adverse event reports per year · DPS

55in 2025

2007: 92008: 172009: 142010: 212011: 1212012: 562013: 152014: 152015: 302016: 122017: 152018: 192019: 272020: 592021: 242022: 592023: 542024: 642025: 55
2007high 121 (2011) · low 9 (2007)2025

MAUDE reports naming product code DPS, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
2007118729
20081331017
20091484114
201011104221
2011221541121
201212117056
201310134015
201411253015
20158178030
201611229012
20179177015
201814221019
20193178927
20206224259
20215135124
20226244159
202310236354
202482604 (1)64
20256163355
202662584—

What is it indicated for?

The Fukuda Denshi CardiMax Model FX-8322 Electrocardiograph is intended to acquire, analyze, display, and record resting electrocardiographic information from adult and pediatric populations. The basic system delivers three (3), six (6) or twelve (12) channels of ECG parameters (waveform, arrhythmia and rhythm measurements, interpretation and heart rate). The device is indicated in situations where an instantaneous display of ECG information or a hard copy record may be required. The device is intended to be used under the direct supervision or a licensed healthcare practitioner, by trained operators in a hospital or medical professional’s facility.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K173226: CardiMax Electrocardiograph.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K173226

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026